Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Association of a variant in the gene encoding for ERV1/ChemR23 with reduced inflammation in visceral adipose tissue from morbidly obese individuals.

López-Vicario C, Rius B, Alcaraz-Quiles J, González-Périz A, Martínez-Puchol AI, Casulleras M, Duran-Güell M, Ibarzabal A, Corcelles R, Laguna-Fernández A, Back M, Titos E, Clària J.

Sci Rep. 2017 Nov 16;7(1):15724. doi: 10.1038/s41598-017-15951-z.

2.

ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages.

Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, Forteza MJ, Jiang X, Andonova T, Walker ME, Dalli J, Arnardottir H, Gisterå A, Thul S, Wheelock CE, Paulsson-Berne G, Ketelhuth DFJ, Hansson GK, Bäck M.

Circulation. 2018 Oct 16;138(16):1693-1705. doi: 10.1161/CIRCULATIONAHA.117.032801.

3.

The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients.

Zabena C, González-Sánchez JL, Martínez-Larrad MT, Torres-García A, Alvarez-Fernández-Represa J, Corbatón-Anchuelo A, Pérez-Barba M, Serrano-Ríos M.

Obes Surg. 2009 Jan;19(1):87-95. doi: 10.1007/s11695-008-9727-0. Epub 2008 Oct 15.

PMID:
18855084
4.

Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue.

Zeyda M, Wernly B, Demyanets S, Kaun C, Hämmerle M, Hantusch B, Schranz M, Neuhofer A, Itariu BK, Keck M, Prager G, Wojta J, Stulnig TM.

Int J Obes (Lond). 2013 May;37(5):658-65. doi: 10.1038/ijo.2012.118. Epub 2012 Jul 17.

PMID:
22828942
5.

Interleukin-17A Gene Expression in Morbidly Obese Women.

Zapata-Gonzalez F, Auguet T, Aragonès G, Guiu-Jurado E, Berlanga A, Martinez S, Martí A, Sabench F, Hernandez M, Aguilar C, Sirvent JJ, Jorba R, Del Castillo D, Richart C.

Int J Mol Sci. 2015 Jul 30;16(8):17469-81. doi: 10.3390/ijms160817469.

6.

ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages.

Herová M, Schmid M, Gemperle C, Hersberger M.

J Immunol. 2015 Mar 1;194(5):2330-7. doi: 10.4049/jimmunol.1402166. Epub 2015 Jan 30.

7.

Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity.

Spoto B, Di Betta E, Mattace-Raso F, Sijbrands E, Vilardi A, Parlongo RM, Pizzini P, Pisano A, Vermi W, Testa A, Cutrupi S, D'Arrigo G, Lonardi S, Tripepi G, Cancarini G, Zoccali C.

Nutr Metab Cardiovasc Dis. 2014 Oct;24(10):1137-43. doi: 10.1016/j.numecd.2014.04.017. Epub 2014 May 27.

PMID:
24984824
8.

Anti-inflammatory profile of FTO gene expression in adipose tissues from morbidly obese women.

Terra X, Auguet T, Porras JA, Quintero Y, Aguilar C, Luna AM, Hernández M, Sabench F, del Castillo D, Richart C.

Cell Physiol Biochem. 2010;26(6):1041-50. doi: 10.1159/000323979. Epub 2011 Jan 4.

9.

Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation.

Barbarroja N, Lopez-Pedrera C, Garrido-Sanchez L, Mayas MD, Oliva-Olivera W, Bernal-Lopez MR, El Bekay R, Tinahones FJ.

PLoS One. 2012;7(10):e48155. doi: 10.1371/journal.pone.0048155. Epub 2012 Oct 24.

10.

Inflammatory Cytokine Profiles in Visceral and Subcutaneous Adipose Tissues of Obese Patients Undergoing Bariatric Surgery Reveal Lack of Correlation With Obesity or Diabetes.

Rakotoarivelo V, Lacraz G, Mayhue M, Brown C, Rottembourg D, Fradette J, Ilangumaran S, Menendez A, Langlois MF, Ramanathan S.

EBioMedicine. 2018 Apr;30:237-247. doi: 10.1016/j.ebiom.2018.03.004. Epub 2018 Mar 8. Erratum in: EBioMedicine. 2018 Nov;37:564-568.

11.

STEAP4 and HIF-1α gene expressions in visceral and subcutaneous adipose tissue of the morbidly obese patients.

Ozmen F, Ozmen MM, Gelecek S, Bilgic İ, Moran M, Sahin TT.

Mol Immunol. 2016 May;73:53-9. doi: 10.1016/j.molimm.2016.03.008. Epub 2016 Apr 6.

PMID:
27058639
12.

Determinants of vitamin D receptor gene expression in visceral and subcutaneous adipose tissue in non-obese, obese, and morbidly obese subjects.

Yuzbashian E, Asghari G, Hedayati M, Zarkesh M, Mirmiran P, Khalaj A.

J Steroid Biochem Mol Biol. 2019 Mar;187:82-87. doi: 10.1016/j.jsbmb.2018.11.004. Epub 2018 Nov 6.

PMID:
30412764
13.

Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss.

Moschen AR, Molnar C, Enrich B, Geiger S, Ebenbichler CF, Tilg H.

Mol Med. 2011;17(7-8):840-5. doi: 10.2119/molmed.2010.00108. Epub 2011 Mar 2.

14.

Interleukin-1β regulates fat-liver crosstalk in obesity by auto-paracrine modulation of adipose tissue inflammation and expandability.

Nov O, Shapiro H, Ovadia H, Tarnovscki T, Dvir I, Shemesh E, Kovsan J, Shelef I, Carmi Y, Voronov E, Apte RN, Lewis E, Haim Y, Konrad D, Bashan N, Rudich A.

PLoS One. 2013;8(1):e53626. doi: 10.1371/journal.pone.0053626. Epub 2013 Jan 16.

15.

Circulating Soluble IL-6 Receptor Concentration and Visceral Adipocyte Size Are Related to Insulin Resistance in Taiwanese Adults with Morbid Obesity.

Kuo FC, Huang YH, Lin FH, Hung YJ, Hsieh CH, Lu CH, Su SC, Huang CL, Lee CH, Chu NF.

Metab Syndr Relat Disord. 2017 May;15(4):187-193. doi: 10.1089/met.2016.0135. Epub 2017 Mar 27.

PMID:
28346858
16.

Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure.

Alcaraz-Quiles J, Titos E, Casulleras M, Pavesi M, López-Vicario C, Rius B, Lopategi A, de Gottardi A, Graziadei I, Gronbaek H, Ginès P, Bernardi M, Arroyo V, Clària J.

Hepatology. 2017 Jan;65(1):202-216. doi: 10.1002/hep.28896. Epub 2016 Nov 28.

PMID:
27775822
17.

MAP3K8 (TPL2/COT) affects obesity-induced adipose tissue inflammation without systemic effects in humans and in mice.

Ballak DB, van Essen P, van Diepen JA, Jansen H, Hijmans A, Matsuguchi T, Sparrer H, Tack CJ, Netea MG, Joosten LA, Stienstra R.

PLoS One. 2014 Feb 24;9(2):e89615. doi: 10.1371/journal.pone.0089615. eCollection 2014.

18.

Genetic contribution to C-reactive protein levels in severe obesity.

Faucher G, Guénard F, Bouchard L, Garneau V, Turcot V, Houde A, Tchernof A, Bergeron J, Deshaies Y, Hould FS, Lebel S, Marceau P, Vohl MC.

Mol Genet Metab. 2012 Mar;105(3):494-501. doi: 10.1016/j.ymgme.2011.11.198. Epub 2011 Dec 2.

PMID:
22178353
19.

CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity.

Huber J, Kiefer FW, Zeyda M, Ludvik B, Silberhumer GR, Prager G, Zlabinger GJ, Stulnig TM.

J Clin Endocrinol Metab. 2008 Aug;93(8):3215-21. doi: 10.1210/jc.2007-2630. Epub 2008 May 20.

PMID:
18492752
20.

Lack of interleukin-1 receptor I (IL-1RI) protects mice from high-fat diet-induced adipose tissue inflammation coincident with improved glucose homeostasis.

McGillicuddy FC, Harford KA, Reynolds CM, Oliver E, Claessens M, Mills KH, Roche HM.

Diabetes. 2011 Jun;60(6):1688-98. doi: 10.2337/db10-1278. Epub 2011 Apr 22.

Supplemental Content

Support Center